{"data":{"ticker":"TVTX","name":"Travere Therapeutics, Inc.","cik":"0001438533","quarterly":[{"frame":"CY2023Q3","end":"2023-09-30","revenue":37095000,"netIncome":150735000,"epsDiluted":1.97,"fiscalPeriod":"Q3 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2023Q4","end":"2023-12-31","revenue":45059000,"netIncome":-90173000,"epsDiluted":-1.18,"fiscalPeriod":"Q4 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2024Q1","end":"2024-03-31","revenue":41374000,"netIncome":-136061000,"epsDiluted":-1.76,"fiscalPeriod":"Q1 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q2","end":"2024-06-30","revenue":54116000,"netIncome":-70409000,"epsDiluted":-0.91,"fiscalPeriod":"Q2 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q3","end":"2024-09-30","revenue":62898000,"netIncome":-54811000,"epsDiluted":-0.7,"fiscalPeriod":"Q3 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q4","end":"2024-12-31","revenue":74787000,"netIncome":-60264000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2025Q1","end":"2025-03-31","revenue":81732000,"netIncome":-41226000,"epsDiluted":-0.47,"fiscalPeriod":"Q1 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q2","end":"2025-06-30","revenue":114449000,"netIncome":-12755000,"epsDiluted":-0.14,"fiscalPeriod":"Q2 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q3","end":"2025-09-30","revenue":164859000,"netIncome":25706000,"epsDiluted":0.28,"fiscalPeriod":"Q3 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q4","end":"2025-12-31","revenue":129688000,"netIncome":2729000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2026Q1","end":"2026-03-31","revenue":127199000,"netIncome":-37102000,"epsDiluted":-0.4,"fiscalPeriod":"Q1 FY 2026","fiscalYear":"FY 2026"},{"frame":"CY2026Q2","end":"2026-06-30","revenue":169584000,"netIncome":-34797000,"epsDiluted":-0.37,"fiscalPeriod":"Q2 FY 2026","fiscalYear":"FY 2026"}],"annual":[{"frame":"CY2020","end":"2020-12-31","fiscalYear":"FY 2020","revenue":198321000,"netIncome":-169431000,"operatingCashFlow":-42743000,"capex":6767000,"buybacks":null,"dividends":null},{"frame":"CY2021","end":"2021-12-31","fiscalYear":"FY 2021","revenue":131836000,"netIncome":-180091000,"operatingCashFlow":-14792000,"capex":5101000,"buybacks":null,"dividends":null},{"frame":"CY2022","end":"2022-12-31","fiscalYear":"FY 2022","revenue":109460000,"netIncome":-278482000,"operatingCashFlow":-186291000,"capex":191000,"buybacks":null,"dividends":null},{"frame":"CY2023","end":"2023-12-31","fiscalYear":"FY 2023","revenue":145238000,"netIncome":-111399000,"operatingCashFlow":-280021000,"capex":668000,"buybacks":null,"dividends":null},{"frame":"CY2024","end":"2024-12-31","fiscalYear":"FY 2024","revenue":233175000,"netIncome":-321545000,"operatingCashFlow":-237475000,"capex":null,"buybacks":null,"dividends":null},{"frame":"CY2025","end":"2025-12-31","fiscalYear":"FY 2025","revenue":490728000,"netIncome":-25546000,"operatingCashFlow":37784000,"capex":null,"buybacks":null,"dividends":null}],"latest":{"end":"2026-06-30","cash":117735000,"debt":null,"equity":24522000,"assets":799360000,"sharesOutstanding":94261082,"sharesDate":"2026-07-30","form":"10-Q"},"source":"SEC XBRL companyfacts, values as filed in USD","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},"updatedAt":"2026-11-04T04:41:22.184Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx","meta":{"source":"SEC","sourceAttribution":"Financial statement data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}